High materiality7/10
Ultragenyx Pharma (RARE) PT Raised to $50 at Wells Fargo
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst Target Update: Wells Fargo raises Ultragenyx PT to $50.
- Wells Fargo raises PT to $50 for RARE.
Key facts
- 01
Target: $50
- 02
Posted price: $26.26
- 03
Analyst firm: Wells Fargo
- 04
Analyst: Ben Burnett
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.